King Faisal Specialist Hospital International Holding Company

What King Faisal Specialist Hospital International Holding Company does

King Faisal Specialist Hospital International Holding Company (KFSHI) is a private Riyadh-based holding company incorporated in 2007 and wholly owned by King Faisal Specialist Hospital & Research Centre (KFSH&RC), a Saudi government-affiliated healthcare institution. KFSHI was established to commercialize advanced healthcare technologies and services beyond the parent's clinical operations, and it pursues this mandate through seven wholly-owned operating subsidiaries spanning diagnostics (Saudi Diagnostic Limited/SDL), medical IT and AI platforms (Al Takassusi General Limited - ITGL), teleradiology and radiopharmaceuticals (Al Takassusi General Limited - RTGL), healthcare outsourcing (Al Takassusi General Limited - OTGL), pharmaceuticals and biomedical products (Takhassusi Bio-Medical/TBM), full-service contract research (TBM-CRO), and strategic medical alliances (Altakassusi Alliance Medical).

The portfolio combines a proprietary technology stack including a generative AI platform for patient flow management, an Electronic Medical Record system, a Patient Pathway Command Center, a Human Genomics Platform supporting personalized medicine, teleradiology services, the SDL Comprehensive Laboratory Test Directory with over 2,900 tests, and hardware-software products such as the Smart Peak Flow device and the Thanaa blockchain-based rewards system. Digital platforms include KFSHI Academy, MedHub, and Takassusi Consult. The Human Genomics Platform and SDL Test Directory are positioned as core technical assets supporting precision medicine and population-scale diagnostics.

KFSHI serves Saudi healthcare institutions, hospitals, laboratories, and medical facilities on a B2B basis, with selective international reach signaled by Global Health Exhibition 2025 participation and the TBM-CRO clinical research offering to pharmaceutical and biotech sponsors. Revenue is generated through professional services contracts, diagnostic testing fees, medical equipment and pharmaceutical distribution, clinical research sponsorships, and outsourced healthcare management. The company aligns its strategy with Saudi Vision 2030 objectives to position the Kingdom as a regional hub for healthcare innovation, leveraging KFSH&RC's 50-year clinical legacy and SFDA regulatory positioning as core commercial assets.

Name

King Faisal Specialist Hospital International Holding Company

Legal name

King Faisal Specialist Hospital International Holding Company

Website

https://kfshi.com.sa

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

King Faisal Specialist Hospital International Holding Company (KFSHI) is a Saudi private holding company wholly owned by KFSH&RC, operating seven healthcare subsidiaries spanning diagnostics, medical IT, teleradiology, outsourcing, biomedical products, clinical research, and medical alliances for B2B healthcare institutions.

Ownership category

akta.pro rank

Product category

Healthcare Technology and Services

NAICS

Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO)

akta.pro secondary industries

Healthcare IT & Health Informatics Staffing (BPACADAK), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Healthcare technology solutions
• Diagnostic laboratory services
• Medical IT platforms
• Clinical research services
• Healthcare outsourcing services

Headquarters

HQ city

Riyadh

HQ country

Saudi Arabia

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Technology Solutions: ITGL provides medical IT solutions, healthcare technology platforms, consulting services, and training to healthcare institutions, generating revenue through project-based engagements and service contracts with hospitals and medical facilities across Saudi Arabia.
2. Diagnostic Laboratory Services: SDL provides diagnostic medical tests, molecular diagnosis, and laboratory management services, generating revenue through laboratory testing fees charged to healthcare providers and institutions.
3. Medical Products Distribution: TBM distributes pharmaceuticals, diagnostic devices, medical equipment for intensive care units, surgical devices, and provides clinical research services, generating revenue through product sales and service fees.
4. Teleradiology and Radiopharmaceutical Services: RTGL provides teleradiology interpretation services and radiopharmaceutical products to healthcare facilities, generating revenue through service fees and product sales.
5. Healthcare Outsourcing Services: OTGL provides specialized outsourcing services in healthcare management including HR management, recruitment, and staffing solutions for healthcare organizations.
6. Clinical Research Services: TBM-CRO provides full-service clinical trial management across all phases, from protocol development to regulatory submissions, generating revenue through contracted research fees from pharmaceutical and biotech sponsors.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

King Faisal Specialist Hospital International Holding Company (KFSHI) is a holding company that operates and invests in subsidiaries delivering healthcare technology, diagnostic laboratory, medical IT, teleradiology, biomedical products, clinical research, and healthcare outsourcing services. Through entities such as Saudi Diagnostic Limited (SDL), Takhassusi Bio-Medical (TBM), ITGL, OTGL, RTGL, TBM-CRO, and Altakassusi Alliance Medical, the group supplies integrated solutions to hospitals, medical laboratories, and pharmaceutical sponsors in Saudi Arabia and beyond.

Product overview

King Faisal Specialist Hospital International Holding Company operates as a holding company overseeing a diversified portfolio of healthcare subsidiaries and platforms. The core subsidiaries include Saudi Diagnostic Limited (SDL) for diagnostic services, Takhassusi Bio-Medical (TBM) for pharmaceuticals and medical devices, ITGL for healthcare technology solutions, OTGL for outsourcing services, RTGL for teleradiology and radiopharmaceuticals, and TBM-CRO for clinical research. These subsidiaries are supported by digital platforms including the Human Genomics Platform for precision medicine, KFSHI Academy for professional education, MedHub for clinical operations, and Takassusi Consult for telemedicine. The company also develops proprietary AI products including a GenAI platform for patient flow management and blockchain-based reward systems, all aligned with Saudi Vision 2030.

Differentiator

Problem solved

Functional benefit

Brands

• KFSHI Academy: Educational platform offering healthcare professional courses in AI, data science, medical coding, digital healthcare innovation and entrepreneurship, operated in collaboration with Phi Science
• SDL Test Directory
• Human Genomics Platform
• Applied Healthcare AI Programs
• MedHub
• Takassusi Consult
• Sanad
• Oraltek & Clustik
• Breek Tech
• Aeolis
• Smart Peak Flow
• ICON
• Thanaa
• TBM-CRO

Products and services

• Saudi Diagnostic Limited (SDL) Specialized diagnostic company providing medical tests, molecular diagnostics, laboratory management, and telemedicine consultations to hospitals, medical laboratories, and healthcare providers across Saudi Arabia.
• Takhassusi Bio-Medical (TBM) Healthcare company supplying pharmaceuticals, in-vitro diagnostic (IVD) equipment, ICU medical equipment, surgical devices, allergy immunotherapy products, and clinical research organization services.
• Al Takassusi General - Information Technology (ITGL) Medical IT and healthcare technology subsidiary providing consulting services, training, operations management, interactive solutions, AI automation, and infrastructure/network services to healthcare institutions.
• Al Takassusi General - Outsourcing (OTGL) Specialized healthcare outsourcing subsidiary providing HR management, medical staffing, and operational efficiency solutions tailored for healthcare organizations.
• Al Takassusi General - Radiology (RTGL) Teleradiology and radiopharmaceutical subsidiary providing remote radiological image interpretation and radioactive pharmaceutical products for medical imaging to healthcare facilities.
• TBM-CRO (Contract Research Organization) Full-service clinical research organization providing protocol development, patient enrollment, data management, and regulatory compliance services across all clinical trial phases for pharmaceutical and biotech sponsors.
• Altakassusi Alliance Medical Strategic partnership platform offering advanced medical imaging services, including molecular imaging, routine imaging, teleradiology, and radiopharmaceutical manufacturing, delivered in collaboration with global medical leaders.
• Human Genomics Platform Cloud-based platform that analyzes and interprets human genetic data to support healthcare providers in delivering personalized medicine.
• KFSHI Academy Online educational platform offering courses in Applied Healthcare AI, Medical Coding, Digital Healthcare Innovation, and Model of Care for healthcare professionals, operated in collaboration with Phi Science.
• MedHub Healthcare management platform that supports clinical operations and patient care coordination within healthcare organizations.
• Takassusi Consult Telemedicine consultation platform connecting healthcare providers with specialists to enable remote medical consultations and second opinions.
• Generative AI Platform for Healthcare AI-powered generative platform for healthcare facilities that centralizes patient flow management, automates administrative tasks, and provides intelligent recommendations to improve operational efficiency and patient safety.
• Electronic Medical Record (EMR) System Digital electronic medical record platform that streamlines clinical documentation and records management for healthcare providers, with intelligent features to reduce administrative burden.
• Patient Pathway Command Center Centralized command center platform that coordinates patient movement and operational workflows within healthcare facilities to improve effectiveness, patient experience, and safety.
• Oraltek and Klinitek Allergy Immunotherapy Sublingual (Oraltek) and subcutaneous (Klinitek) immunotherapy products for the treatment of allergic conditions including asthma, rhinitis, and conjunctivitis.
• Prick Tech Skin Prick Testing Device Skin prick testing device registered in Saudi Arabia for diagnosing allergic reactions to inhalant and food allergens, branded as Breek Tech.
• Aiolis Air Purifiers Portable medical air purification devices equipped with HEPA 13 or ULPA 15 filters, UV-C radiation, and active oxygen generators for clinical and healthcare environments.
• Smart Peak Flow Combined hardware and software solution for asthma patients that measures lung function via a Bluetooth-connected peak flow device and a mobile app for tracking and charting progress.
• ICON Hemodynamic Monitor Non-invasive hemodynamic monitoring device that uses ECG measurement technology to assess cardiovascular status in neonates, children, and adults across Saudi Arabia.
• ALEX2 Allergy Testing Solutions Macro Array Diagnostics allergy testing equipment including ALEX2 IgE antibody testing, FOX IgG testing, and automated MAX 45k laboratory devices.
• Tanaween Blockchain Rewards System Blockchain-based performance rewards system built on Hyperledger Fabric and using THT Token to recognize exceptional performance within organizations and enable secure transactions and health goal synchronization.
• SDL Comprehensive Laboratory Test Directory Comprehensive directory of more than 2,900 medical tests across general diagnostics, immunology, pathology, genetics, hematology, microbiology, oncology, endocrinology, biochemistry, clinical chemistry, and prenatal testing, providing sample type, turnaround time, scientific description, and preparation notes.

Quantifiable outcome

• 2,900+ medical tests available across diverse specialties through SDL's Comprehensive Laboratory Test Directory
• +1 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core.

• SCAI (Saudi Company for Artificial Intelligence)coreStrategic or Co-development Partner · 1 January 2024Strategic partnership with SCAI signed during the Gain Summit to develop innovative AI solutions for improving efficiency and quality in the healthcare sector. The collaboration focuses on AI-driven projects that enhance patient care and support advanced healthcare systems, aligned with Saudi Vision 2030.
• Phi SciencecoreStrategic or Co-development Partner · 1 January 2024Joint collaboration agreement with Phi Science signed during Gain Summit to strengthen artificial intelligence capabilities in healthcare. The partnership focuses on developing innovative AI-driven solutions to support medical diagnostics and improve healthcare quality, marking a significant step toward leveraging advanced technology to enhance the future of healthcare in Saudi Arabia.
• Altakassusi Alliance MedicalcoreStrategic or Co-development PartnerStrategic partnership dedicated to delivering advanced healthcare solutions through collaboration with global medical leaders. Focuses on providing comprehensive medical services, leveraging international expertise to bring world-class healthcare standards to the region.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Global contract research organization providing clinical trial and laboratory services. Comparable for TBM-CRO as an internationally scaled CRO that may compete for trials conducted in Saudi Arabia and the broader MENA region.
• IQVIA: Global clinical research, healthcare data, and life sciences technology leader. Comparable for KFSHI's TBM-CRO subsidiary as a large-scale, globally established CRO competing for the same pharma and biotech sponsor mandates.
• Dr. Sulaiman Al-Habib Medical Services Group (HMG): One of Saudi Arabia's largest private hospital and healthcare groups, listed on Tadawul. Comparable as a leading Saudi healthcare provider with its own digital health and diagnostics capabilities, competing for the same institutional and tertiary-care customers.

Regional players

• National Medical Care Company (CARE): Saudi-listed healthcare provider operating hospitals and ancillary healthcare services. Comparable as a regionally-focused healthcare group operating within the same Saudi institutional customer base as KFSHI's subsidiaries.
• NMC Healthcare: UAE-headquartered hospital and healthcare group with operations across the Gulf. Comparable as a Gulf-based hospital group operating in adjacent geographies to KFSHI's MENA footprint.
• Dallah Healthcare Holding: Saudi-listed hospital and healthcare holding company operating multiple facilities and healthcare services across the Kingdom. Comparable as a Saudi healthcare holding with diversified operating subsidiaries.
• Saudi German Health Group: One of the largest private hospital networks in the MENA region, headquartered in Saudi Arabia. Comparable as a regionally-diversified healthcare provider competing for Saudi tertiary-care and specialty contracts.
• Mouwasat Medical Services: Saudi-listed hospital and healthcare services operator with facilities across multiple Saudi cities. Comparable as a domestic Saudi healthcare group sharing the same patient and institutional demand drivers.

Direct peers

• PureHealth: UAE-based healthcare holding company operating hospitals, diagnostics, and health-tech platforms across the Gulf. Structurally the closest analog to KFSHI: a state-aligned holding that commercializes clinical and digital health assets through multiple subsidiaries and partnerships.

Others

• King Faisal Specialist Hospital & Research Centre (KFSH&RC): The Saudi government healthcare, research, and education institution that owns KFSHI. KFSHI was created to commercialize KFSH&RC's clinical and technological IP, so the parent is both the anchor reference customer and the governance overlord.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/saudi-kfshi-holding-co

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about King Faisal Specialist Hospital International Holding Company